InspireMD, Inc. NSPR
0.54 USD -0.08 (-12.97%)
Regular-session close
0.51 -0.03 -5.93%
After hours · Nov 20, 5:45 PM ET
0.4999 Day range 0.63
0.44 52-week range 2.15
- YTD
- -69.66%
- 1 year
- -68.24%
News
globenewswire.com InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MIAMI, Nov. 20, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today…
seekingalpha.com InspireMD, Inc. (NSPR) Discusses Carotid Artery Disease Management and CGuard Prime Clinical Benefits Transcript InspireMD, Inc. (NSPR) Discusses Carotid Artery Disease Management and CGuard Prime Clinical Benefits Transcriptbenzinga.com InspireMD Completes First U.S. Commercial Transcarotid Artery Revascularization Procedures Utilizing Its CGuard Prime TransCarotid Stent System - First commercial cases mark return of the CGuard Prime platform to the U.S. market -- Milestone expands commercial application of proprietary MicroNet™ Mesh-covered CGuard Prime stent platform to…
globenewswire.com InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard® Prime TransCarotid Stent System - First commercial cases mark return of the CGuard Prime platform to the U.S. market - - Milestone expands commercial application of proprietary MicroNet™ Mesh-covered CGuard Prime stent platform to…
globenewswire.com InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD's CGuard Prime Carotid Stent Platform Participating KOLs include six leading physician experts representing vascular surgery, interventional cardiology, vascular medicine, and neurosurgery
zacks.com InspireMD (NSPR) Upgraded to Buy: Here's Why InspireMD (NSPR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
globenewswire.com InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026 MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) stock rose 19.6% to $9.6 during Friday's pre-market session. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3…benzinga.com Update: InspireMD Q3 Adj. EPS $(0.11) Beats $(0.15) Estimate, Sales $2.242M Beat $1.996M Estimate InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 35.29 percent increase over losses of $(0.17)…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Oragenics (AMEX:OGEN) stock increased by 30.2% to $0.46 during Thursday's after-market session. The market value of their outstanding shares is at $1.5 million. InspireMD (NASDAQ:NSPR) shares…benzinga.com InspireMD Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $2.242M Beat $1.996M Estimate. Cash and Equivalents $19.246M InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 29.41 percent increase over losses of $(0.17) per…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million. BeyondSpring (NASDAQ:BYSI) stock moved…
